Effects of a novel bicycle saddle on symptoms and comfort in cyclists

Background. While the bicycle frame and other parts of the bicycle have undergone many improvements, the bicycle saddle has remained relatively unchanged since it was first designed more than 100 years ago. Given the number and range of cycling injuries believed to result from the saddle, this is surprising. This study investigated the effects of a novel bicycle saddle on saddle-related comfort and symptoms during cycling.Method. Eleven competitive or recreational cyclists, 6 females and 5 males, performed three 2-hour stationary cycle rides in the laboratory, using their personal bicycles. Ride 1 was performed using the standard bicycle saddle and rides 2 and 3 using the novel bicycle saddle. Subjects reported saddle comfort rating scores (SC) while using the different saddles. Subjects also completed a questionnaire evaluating saddle symptoms (SS) when using either the conventional or the novel bicycle saddle during daily cycling.Results. The most common saddle-related medical complaint with chronic use of the conventional saddle was painful pubic bones, with or without chafing. Others were severe chafing, saddle sores, chafing and back pain, and painful pubic bones associated with a loss of feeling in the pelvic area. The mean SS rating score during the 2-hour laboratory ride was significantly less for the novel saddle (11.6 ± 1.2 versus 19.1 ± 3.2 arbitrary units, P < 0.01). Similarly the mean SC score was significantly lower for the novel saddle (36.2 ± 10.5 v. 54.7 ± 11.2 arbitrary units). Values for both SC scores were similar for rides 2 and 3. On completion of the trial all subjects indicated that they would continue to use the novel saddle in preference to the conventional saddle. Three months later 9 subjects (82%) reported continued use of this saddle in preference to the conventional saddle.Conclusion. These results show conclusively that this novel bicycle saddle: (i) significantly reduced reported symptoms during daily cycling compared with the conventionally designed cycling saddle; (ii) significantly improved saddle comfort during 2-.hour cycles in the laboratory, such that (iii) when given the option the majority (82%) of the subjects chose to use this saddle 3 months later. Furthermore, the beneficial effects of the novel saddle were apparent during its first use, suggesting that the novel saddle is effective because the design is anatomically correct

Noble gas films on a decagonal AlNiCo quasicrystal

Thermodynamic properties of Ne, Ar, Kr, and Xe adsorbed on an Al-Ni-Co quasicrystalline surface (QC) are studied with Grand Canonical Monte Carlo by employing Lennard-Jones interactions with parameter values derived from experiments and traditional combining rules. In all the gas/QC systems, a layer-by-layer film growth is observed at low temperature. The monolayers have regular epitaxial fivefold arrangements which evolve toward sixfold close-packed structures as the pressure is increased. The final states can contain either considerable or negligible amounts of defects. In the latter case, there occurs a structural transition from five to sixfold symmetry which can be described by introducing an order parameter, whose evolution characterizes the transition to be continuous or discontinuous as in the case of Xe/QC (first-order transition with associated latent heat). By simulating fictitious noble gases, we find that the existence of the transition is correlated with the size mismatch between adsorbate and substrate's characteristic lengths. A simple rule is proposed to predict the phenomenon.Comment: 19 pages. 8 figures. (color figures can be seen at http://alpha.mems.duke.edu/wahyu/ or http://www.iop.org/EJ/abstract/0953-8984/19/1/016007/

Coexistence of ferromagnetism and superconductivity in the hybrid ruthenate-cuprate compound RuSr_2GdCu_2O_8 studied by muon spin rotation (\mu SR) and DC-magnetization

We have investigated the magnetic and the superconducting properties of the hybrid ruthenate-cuprate compound RuSr_{2}GdCu_{2}O_{8} by means of zero-field muon spin rotation- (ZF-$\mu$SR) and DC magnetization measurements. The DC-magnetisation data establish that this material exhibits ferromagnetic order of the Ru-moments ($\mu (Ru) \approx 1 \mu_{B}$) below T_{Curie} = 133 K and becomes superconducting at a much lower temperature T_c = 16 K. The ZF-$\mu$SR experiments indicate that the ferromagnetic phase is homogeneous on a microscopic scale and accounts for most of the sample volume. They also suggest that the magnetic order is not significantly modified at the onset of superconductivity.Comment: improved version submitted to Phys. Rev.

Incommensurate Spin Density Waves in Iron Aluminides

Neutron diffraction in Fe(Al) reveals incommensurate spin density waves (SDWs) in alloys known to be spin glasses. The wave vectors for crystals of Fe(34Al), Fe(40Al), and Fe(43Al) show n varying from 11 to 6 for →q=2π(h±1/n,k±1/n,l±1/n)/a0, where (h,k,l) and a0 characterize the parent bcc lattice of the CsCl structure. The magnetic reflections are present far above the spin-glass freezing temperatures. These SDWs keep the spins on nearest-neighbor Fe atoms close to parallel, in contrast with SDWs in Cr, which keep nearest-neighbor spins close to antiparallel

Invariant higher-order variational problems II

Motivated by applications in computational anatomy, we consider a second-order problem in the calculus of variations on object manifolds that are acted upon by Lie groups of smooth invertible transformations. This problem leads to solution curves known as Riemannian cubics on object manifolds that are endowed with normal metrics. The prime examples of such object manifolds are the symmetric spaces. We characterize the class of cubics on object manifolds that can be lifted horizontally to cubics on the group of transformations. Conversely, we show that certain types of non-horizontal geodesics on the group of transformations project to cubics. Finally, we apply second-order Lagrange--Poincar\'e reduction to the problem of Riemannian cubics on the group of transformations. This leads to a reduced form of the equations that reveals the obstruction for the projection of a cubic on a transformation group to again be a cubic on its object manifold.Comment: 40 pages, 1 figure. First version -- comments welcome

Composition profiles of InAs–GaAs quantum dots determined by medium-energy ion scattering

The composition profile along the [001] growth direction of low-growth-rate InAs–GaAs quantum dots (QDs) has been determined using medium-energy ion scattering (MEIS). A linear profile of In concentration from 100% In at the top of the QDs to 20% at their base provides the best fit to MEIS energy spectra

Caffeine ingestion does not alter performance during a 100-km cycling time-trial performance

This study analyzed the effect of caffeine ingestion on performance during a repeated-measures, 100-km, laboratory cycling time trial that included bouts of 1- and 4-km high intensity epochs (HIE). Eight highly trained cyclists participated in 3 separate trials - placebo ingestion before exercise with a placebo carbohydrate solution and placebo tablets during exercise (Pl), or placebo ingestion before exercise with a 7% carbohydrate drink and placebo tablets during exercise (Cho), or caffeine tablet ingestion before and during exercise with 7% carbohydrate (Caf). Placebo (twice) or 6 mg · kg-1 caffeine was ingested 60 min prior to starting 1 of the 3 cycling trials, during which subjects ingested either additional placebos or a caffeine maintenance dose of 0.33 mg · kg-1 every 15 min to trial completion. The 100-km time trial consisted of five 1-km HIE after 10, 32, 52, 72, and 99 km, as well as four 4-km HIE after 20, 40, 60, and 80 km. Subjects were instructed to complete the time trial and all HIE as fast as possible. Plasma (caffeine) was significantly higher during Caf (0.43 ± 0.56 and 1.11 ± 1.78 mM pre vs. post Pl; and 47.32 ± 12.01 and 72.43 ± 29.08 mM pre vs. post Caf). Average power, HIE time to completion, and 100-km time to completion were not different between trials. Mean heart rates during both the 1-km HIE (184.0 ± 9.8 Caf; 177.0 ± 5.8 Pl; 177.4 ± 8.9 Cho) and 4-km HIE (181.7 ± 5.7 Caf; 174.3 ± 7.2 Pl; 175.6 ± 7.6 Cho;p less than .05) was higher in Caf than in the other groups. No significant differences were found between groups for either EMG amplitude (IEMG) or mean power frequency spectrum (MPFS). IEMG activity and performance were not different between groups but were both higher in the 1-km HIE, indicating the absence of peripheral fatigue and the presence of a centrally-regulated pacing strategy that is not altered by caffeine ingestion. Caffeine may be without ergogenic benefit during endurance exercise in which the athlete begins exercise with a defined, predetermined goal measured as speed or distance

Gc protein-derived macrophage-activating factor decreases alpha-N-acetylgalactosaminidase levels in advanced cancer patients

α-N-acetylgalactosaminidase (nagalase) accumulates in the serum of cancer patients and its activity correlates with tumor burden, aggressiveness and clinical disease progression. The administration of GC protein-derived macrophage-activating factor (GcMAF) to cancer patients with elevated levels of nagalase has been associated with a decrease of serum nagalase activity and with significant clinical benefits. Here, we report the results of the administration of GcMAF to a heterogeneous cohort of patients with histologically diverse, advanced neoplasms, generally considered as “incurable” diseases. In most cases, GcMAF therapy was initiated at late stages of tumor progression. As this is an open-label, non-controlled, retrospective analysis, caution must be employed when establishing cause-effect relationships between the administration GcMAF and disease outcome. However, the response to GcMAF was generally robust and some trends emerged. All patients (n = 20) presented with elevated serum nagalase activity, well above normal values. All patients but one showed a significant decrease of serum nagalase activity upon weekly GcMAF injections. Decreased nagalase activity was associated with improved clinical conditions and no adverse side effects were reported. The observations reported here confirm and extend previous results and pave the way to further studies aimed at assessing the precise role and indications for GcMAF-based anticancer immunotherapy